MCMedicalCodingSoftware
J1941

J1941: Injection, furosemide (furoscix), 20 mg

HCPCSTerminatedBETOS O1E

J1941 is a HCPCS Level II code for injection, furosemide (furoscix), 20 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on September 30, 2026 and is not valid on new claims.

This code has been terminated

CMS terminated J1941 on September 30, 2026. It stays in the file as history: a claim you are auditing from before that date may legitimately carry it, but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q4-Oct. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

The CMS record for J1941

Long descriptor
Injection, furosemide (furoscix), 20 mg

The official wording. This is what the code means.

Short descriptor
Inj, furoscix, 20 mg

CMS's 28-character form, which is what shows up on a remittance advice.

Added
July 1, 2023

When CMS introduced the code.

Terminated
September 30, 2026

When CMS retired it.

BETOS
O1E

Berenson-Eggers Type of Service: CMS's own analytic grouping.

Pricing indicator
51: Other

Drugs.

Codes adjacent to J1941

HCPCS has no hierarchy: related items simply sit next to each other in the numbering. If J1941 is not quite right, the correct code is very often within a few positions of it.

  • J1920Injection, labetalol hydrochloride, 5 mg
  • J1921Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg
  • J1930Injection, lanreotide, 1 mg
  • J1931Injection, laronidase, 0.1 mg
  • J1932Injection, lanreotide, (cipla), 1 mg
  • J1938Injection, furosemide, 1 mg
  • J1939Injection, bumetanide, 0.5 mg
  • J1940Injection, furosemide, up to 20 mgterminated
  • J1942Injection, aripiprazole lauroxil, 1 mgterminated
  • J1943Injection, aripiprazole lauroxil, (aristada initio), 1 mg
  • J1944Injection, aripiprazole lauroxil, (aristada), 1 mg
  • J1945Injection, lepirudin, 50 mgterminated
  • J1946Injection, furosemide (lasix onyu), 1 mg
  • J1947Injection, furosemide (furoscix), 1 mg
  • J1950Injection, leuprolide acetate (for depot suspension), per 3.75 mg
  • J1951Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg
HCPCS Level II2026Q4-Oct· effective October 1, 2026